The Role of Systemic Handling in the Pathophysiologic Actions of Botulinum Toxin
- 6 June 2008
- journal article
- research article
- Published by American Society for Pharmacology & Experimental Therapeutics (ASPET) in Journal of Pharmacology and Experimental Therapeutics
- Vol. 326 (3), 856-863
- https://doi.org/10.1124/jpet.108.136242
Abstract
The ability of botulinum toxin to poison cholinergic nerve transmission is a dynamic phenomenon that involves not only the actions of the toxin on the body but also the actions of the body on the toxin. The former has been the subject of intense research, whereas the latter has received almost no attention. Therefore, a series of studies were performed to characterize systemic handling of botulinum toxin. The results indicated that the toxin reaches the general circulation (transcytosis across epithelial cells) without obvious changes in structure or biological activity. The general circulation acts as a holding compartment until there is adequate fractional distribution to neuromuscular junctions to produce blockade of transmission. During its transit through this compartment, the toxin 1) undergoes little biotransformation, 2) does not accumulate significantly in circulating cells, and 3) remains largely in the free state. In naive animals, the t1/2 for toxin in the general circulation is approximately 10 h, and at any given point in time, there is little uptake in nontarget organs (liver, kidney, heart, and lung). In immunized animals, toxin clearance from the general circulation is rapid, and there is substantial accumulation of antibody-antigen complexes in liver. Thus, enhanced clearance from the circulation is a major mechanism by which active immunization can protect against poisoning.Keywords
This publication has 23 references indexed in Scilit:
- Clostridial neurotoxins: structure-function led design of new therapeuticsCellular and Molecular Life Sciences, 2006
- Visualization of Binding and Transcytosis of Botulinum Toxin by Human Intestinal Epithelial CellsJournal of Pharmacology and Experimental Therapeutics, 2005
- Botulinum Toxins: Transformation of a Toxin into a TreatmentPublished by Elsevier BV ,2005
- Structural Features of the Botulinum Neurotoxin Molecule That Govern Binding and Transcytosis across Polarized Human Intestinal Epithelial CellsJournal of Pharmacology and Experimental Therapeutics, 2004
- Botulinum Toxin as a Biological WeaponJAMA, 2001
- How botulinum and tetanus neurotoxins block neurotransmitter release**This paper is dedicated to the memory of Heiner Niemann.Biochimie, 2000
- Pharmacokinetics of Heterologous and Homologous Immunoglobulin G, F(ab‘)2 and Fab after Intravenous Administration in the RatJournal of Pharmacy and Pharmacology, 1997
- Therapeutic Uses of Botulinum ToxinNew England Journal of Medicine, 1991
- Pharmakokinetische Besonderheiten des Tetanustoxins und ihre Beziehungen zur Pathogenese des lokalen bzw. generalisierten TetanusNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1970
- The action of botulinum toxin on the neuro‐muscular junctionThe Journal of Physiology, 1949